Pharmacogenomics (PGx) in Practice: Germline Oncology (2024)
Issued by
University of Pittsburgh
Earners of this micro-credential have demonstrated competency in pharmacogenomics (PGx) concepts and their application to oncology clinical practice. They are able to make appropriate recommendations for germline PGx testing, interpret results, integrate these data into patient care decisions, counsel patients, and collaborate with prescribers to help optimize patient medication regimens.
- Type Validation
- Level Intermediate
- Cost Paid
Earning Criteria
-
Completed 5 hours of self-paced, online education involving videos, interactive activities, case-based assessments, and readings.
-
Achieved a minimum 80% score on 6 individual assessments focused on precision medicine and PGx, foundations of PGx, PGx testing, clinical decision making, and the integration of PGx into oncology practice.
Standards
The program was designed to fulfill competency standards for pharmacists, physicians, nurses, and physician assistants.